SRS Capital Advisors »

Ishares Tr genomics immun shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.8k 205 23.61
2025-06-30 $4.2k 205 20.51

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Ishares Tr genomics immun

UBS Group
Wharton Business Group
Raymond James Financial
Morgan Stanley
Portland Global Advisors
Ameriprise Financial
Royal Bank of Canada
Jane Street
LPL Financial
Bsc Private Wealth Management
Lido Advisors
Nelson, Van Denburg & Campbell Wealth Management
Commonwealth Equity Services
Flow Traders US
Cambridge Investment Research Advisors

View all funds holding Ishares Tr genomics immun